FDA 510(k) Clearance For Accuray’s CyberKnife® M6™ Series

Accuray company, today announced that the company received 510(k) clearance from the U.S. Food and Drug Administration (FDA) for its new CyberKnife M6(TM) Series. The CyberKnife M6 Series features expanded clinical capabilities, reduced treatment times and an enhanced patient experience.



Accuray Receives FDA 510(k) Clearance for New CyberKnife® M6™ Series, Merging Multileaf Collimation with Non-Isocentric Robotic Delivery (via PR Newswire)

SUNNYVALE, Calif., Nov. 1, 2012 /PRNewswire/ — Accuray Incorporated (Nasdaq: ARAY), the premier radiation oncology company, today announced that the company received 510(k) clearance from the U.S. Food and Drug Administration (FDA) for its new CyberKnife® M6™ Series. The CyberKnife M6 Series features…


published: November 1, 2012 in: Approval/Clearance, Oncology, Technology

Most read

Latest

^